Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
51
DGX Quote, Financials, Valuation and Earnings
Last price:
$202.35
Seasonality move
:
9.28%
Day range:
$200.94 - $204.42
52-week range:
$157.20 - $213.20
Dividend yield:
1.58%
P/E ratio:
23.12x
P/S ratio:
2.07x
P/B ratio:
3.11x
Volume:
642.1K
Avg. volume:
1.2M
1-year change:
17.58%
Market cap:
$22.3B
Revenue:
$11B
EPS (TTM):
$8.76
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
DGX
Quest Diagnostics, Inc.
|
$2.8B | $2.36 | 6.75% | 21.83% | $217.38 |
|
DHR
Danaher Corp.
|
$6.8B | $2.19 | 4.53% | 46.46% | $264.91 |
|
EXAS
EXACT Sciences Corp.
|
$860.8M | $0.08 | 18.03% | -84.17% | $105.81 |
|
GH
Guardant Health, Inc.
|
$272.3M | -$0.47 | 37.41% | -38.78% | $130.45 |
|
LH
Labcorp Holdings, Inc.
|
$3.6B | $3.94 | 5.03% | 63.98% | $305.88 |
|
WAT
Waters Corp.
|
$928.7M | $4.51 | 81.77% | 13.77% | $398.05 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
DGX
Quest Diagnostics, Inc.
|
$202.41 | $217.38 | $22.3B | 23.12x | $0.80 | 1.58% | 2.07x |
|
DHR
Danaher Corp.
|
$209.50 | $264.91 | $148.1B | 41.51x | $0.32 | 0.61% | 6.11x |
|
EXAS
EXACT Sciences Corp.
|
$103.43 | $105.81 | $19.7B | -- | $0.00 | 0% | 6.01x |
|
GH
Guardant Health, Inc.
|
$103.10 | $130.45 | $13.4B | -- | $0.00 | 0% | 13.16x |
|
LH
Labcorp Holdings, Inc.
|
$282.67 | $305.88 | $23.4B | 27.03x | $0.72 | 1.02% | 1.70x |
|
WAT
Waters Corp.
|
$333.33 | $398.05 | $32.7B | 30.96x | $0.00 | 0% | 6.29x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
DGX
Quest Diagnostics, Inc.
|
47.09% | -0.045 | 33.16% | 0.80x |
|
DHR
Danaher Corp.
|
25.96% | 0.180 | 11.38% | 1.27x |
|
EXAS
EXACT Sciences Corp.
|
51.36% | 1.552 | 13.08% | 1.97x |
|
GH
Guardant Health, Inc.
|
106.17% | 0.817 | 12.89% | 4.42x |
|
LH
Labcorp Holdings, Inc.
|
43.09% | 0.762 | 31.35% | 0.99x |
|
WAT
Waters Corp.
|
35.46% | 0.429 | 6.22% | 0.98x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
DGX
Quest Diagnostics, Inc.
|
$914M | $391M | 7.6% | 14.49% | 13.93% | $307M |
|
DHR
Danaher Corp.
|
$4B | $1.5B | 5.2% | 7.02% | 21.97% | $1.7B |
|
EXAS
EXACT Sciences Corp.
|
$615.8M | -$76.7M | -4.14% | -8.54% | -8.73% | $120.4M |
|
GH
Guardant Health, Inc.
|
$181.8M | -$120.3M | -35.5% | -8518.58% | -42.76% | -$41.9M |
|
LH
Labcorp Holdings, Inc.
|
$920.6M | $382M | 5.8% | 10.39% | 10.87% | $490.3M |
|
WAT
Waters Corp.
|
$557.4M | $310.6M | 17.36% | 29.63% | 33.31% | $125.6M |
Quest Diagnostics, Inc. vs. Competitors
-
Which has Higher Returns DGX or DHR?
Danaher Corp. has a net margin of 9.12% compared to Quest Diagnostics, Inc.'s net margin of 17.3%. Quest Diagnostics, Inc.'s return on equity of 14.49% beat Danaher Corp.'s return on equity of 7.02%.
Company Gross Margin Earnings Per Share Invested Capital DGXQuest Diagnostics, Inc.32.57% $2.18 $13.7B DHRDanaher Corp.58% $1.68 $71B -
What do Analysts Say About DGX or DHR?
Quest Diagnostics, Inc. has a consensus price target of $217.38, signalling upside risk potential of 7.39%. On the other hand Danaher Corp. has an analysts' consensus of $264.91 which suggests that it could grow by 26.45%. Given that Danaher Corp. has higher upside potential than Quest Diagnostics, Inc., analysts believe Danaher Corp. is more attractive than Quest Diagnostics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings DGXQuest Diagnostics, Inc.7 7 0 DHRDanaher Corp.18 3 0 -
Is DGX or DHR More Risky?
Quest Diagnostics, Inc. has a beta of 0.662, which suggesting that the stock is 33.785% less volatile than S&P 500. In comparison Danaher Corp. has a beta of 0.916, suggesting its less volatile than the S&P 500 by 8.434%.
-
Which is a Better Dividend Stock DGX or DHR?
Quest Diagnostics, Inc. has a quarterly dividend of $0.80 per share corresponding to a yield of 1.58%. Danaher Corp. offers a yield of 0.61% to investors and pays a quarterly dividend of $0.32 per share. Quest Diagnostics, Inc. pays 36.57% of its earnings as a dividend. Danaher Corp. pays out 25.35% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios DGX or DHR?
Quest Diagnostics, Inc. quarterly revenues are $2.8B, which are smaller than Danaher Corp. quarterly revenues of $6.8B. Quest Diagnostics, Inc.'s net income of $256M is lower than Danaher Corp.'s net income of $1.2B. Notably, Quest Diagnostics, Inc.'s price-to-earnings ratio is 23.12x while Danaher Corp.'s PE ratio is 41.51x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quest Diagnostics, Inc. is 2.07x versus 6.11x for Danaher Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DGXQuest Diagnostics, Inc.2.07x 23.12x $2.8B $256M DHRDanaher Corp.6.11x 41.51x $6.8B $1.2B
-
Which has Higher Returns DGX or EXAS?
EXACT Sciences Corp. has a net margin of 9.12% compared to Quest Diagnostics, Inc.'s net margin of -9.79%. Quest Diagnostics, Inc.'s return on equity of 14.49% beat EXACT Sciences Corp.'s return on equity of -8.54%.
Company Gross Margin Earnings Per Share Invested Capital DGXQuest Diagnostics, Inc.32.57% $2.18 $13.7B EXASEXACT Sciences Corp.70.11% -$0.45 $4.9B -
What do Analysts Say About DGX or EXAS?
Quest Diagnostics, Inc. has a consensus price target of $217.38, signalling upside risk potential of 7.39%. On the other hand EXACT Sciences Corp. has an analysts' consensus of $105.81 which suggests that it could grow by 2.3%. Given that Quest Diagnostics, Inc. has higher upside potential than EXACT Sciences Corp., analysts believe Quest Diagnostics, Inc. is more attractive than EXACT Sciences Corp..
Company Buy Ratings Hold Ratings Sell Ratings DGXQuest Diagnostics, Inc.7 7 0 EXASEXACT Sciences Corp.1 20 0 -
Is DGX or EXAS More Risky?
Quest Diagnostics, Inc. has a beta of 0.662, which suggesting that the stock is 33.785% less volatile than S&P 500. In comparison EXACT Sciences Corp. has a beta of 1.416, suggesting its more volatile than the S&P 500 by 41.594%.
-
Which is a Better Dividend Stock DGX or EXAS?
Quest Diagnostics, Inc. has a quarterly dividend of $0.80 per share corresponding to a yield of 1.58%. EXACT Sciences Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quest Diagnostics, Inc. pays 36.57% of its earnings as a dividend. EXACT Sciences Corp. pays out -- of its earnings as a dividend. Quest Diagnostics, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios DGX or EXAS?
Quest Diagnostics, Inc. quarterly revenues are $2.8B, which are larger than EXACT Sciences Corp. quarterly revenues of $878.4M. Quest Diagnostics, Inc.'s net income of $256M is higher than EXACT Sciences Corp.'s net income of -$86M. Notably, Quest Diagnostics, Inc.'s price-to-earnings ratio is 23.12x while EXACT Sciences Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quest Diagnostics, Inc. is 2.07x versus 6.01x for EXACT Sciences Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DGXQuest Diagnostics, Inc.2.07x 23.12x $2.8B $256M EXASEXACT Sciences Corp.6.01x -- $878.4M -$86M
-
Which has Higher Returns DGX or GH?
Guardant Health, Inc. has a net margin of 9.12% compared to Quest Diagnostics, Inc.'s net margin of -45.68%. Quest Diagnostics, Inc.'s return on equity of 14.49% beat Guardant Health, Inc.'s return on equity of -8518.58%.
Company Gross Margin Earnings Per Share Invested Capital DGXQuest Diagnostics, Inc.32.57% $2.18 $13.7B GHGuardant Health, Inc.64.63% -$1.00 $1.6B -
What do Analysts Say About DGX or GH?
Quest Diagnostics, Inc. has a consensus price target of $217.38, signalling upside risk potential of 7.39%. On the other hand Guardant Health, Inc. has an analysts' consensus of $130.45 which suggests that it could grow by 26.53%. Given that Guardant Health, Inc. has higher upside potential than Quest Diagnostics, Inc., analysts believe Guardant Health, Inc. is more attractive than Quest Diagnostics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings DGXQuest Diagnostics, Inc.7 7 0 GHGuardant Health, Inc.17 1 1 -
Is DGX or GH More Risky?
Quest Diagnostics, Inc. has a beta of 0.662, which suggesting that the stock is 33.785% less volatile than S&P 500. In comparison Guardant Health, Inc. has a beta of 1.631, suggesting its more volatile than the S&P 500 by 63.129%.
-
Which is a Better Dividend Stock DGX or GH?
Quest Diagnostics, Inc. has a quarterly dividend of $0.80 per share corresponding to a yield of 1.58%. Guardant Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quest Diagnostics, Inc. pays 36.57% of its earnings as a dividend. Guardant Health, Inc. pays out -- of its earnings as a dividend. Quest Diagnostics, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios DGX or GH?
Quest Diagnostics, Inc. quarterly revenues are $2.8B, which are larger than Guardant Health, Inc. quarterly revenues of $281.3M. Quest Diagnostics, Inc.'s net income of $256M is higher than Guardant Health, Inc.'s net income of -$128.5M. Notably, Quest Diagnostics, Inc.'s price-to-earnings ratio is 23.12x while Guardant Health, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quest Diagnostics, Inc. is 2.07x versus 13.16x for Guardant Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DGXQuest Diagnostics, Inc.2.07x 23.12x $2.8B $256M GHGuardant Health, Inc.13.16x -- $281.3M -$128.5M
-
Which has Higher Returns DGX or LH?
Labcorp Holdings, Inc. has a net margin of 9.12% compared to Quest Diagnostics, Inc.'s net margin of 4.69%. Quest Diagnostics, Inc.'s return on equity of 14.49% beat Labcorp Holdings, Inc.'s return on equity of 10.39%.
Company Gross Margin Earnings Per Share Invested Capital DGXQuest Diagnostics, Inc.32.57% $2.18 $13.7B LHLabcorp Holdings, Inc.26.19% $1.98 $15.2B -
What do Analysts Say About DGX or LH?
Quest Diagnostics, Inc. has a consensus price target of $217.38, signalling upside risk potential of 7.39%. On the other hand Labcorp Holdings, Inc. has an analysts' consensus of $305.88 which suggests that it could grow by 8.21%. Given that Labcorp Holdings, Inc. has higher upside potential than Quest Diagnostics, Inc., analysts believe Labcorp Holdings, Inc. is more attractive than Quest Diagnostics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings DGXQuest Diagnostics, Inc.7 7 0 LHLabcorp Holdings, Inc.12 5 0 -
Is DGX or LH More Risky?
Quest Diagnostics, Inc. has a beta of 0.662, which suggesting that the stock is 33.785% less volatile than S&P 500. In comparison Labcorp Holdings, Inc. has a beta of 1.029, suggesting its more volatile than the S&P 500 by 2.876%.
-
Which is a Better Dividend Stock DGX or LH?
Quest Diagnostics, Inc. has a quarterly dividend of $0.80 per share corresponding to a yield of 1.58%. Labcorp Holdings, Inc. offers a yield of 1.02% to investors and pays a quarterly dividend of $0.72 per share. Quest Diagnostics, Inc. pays 36.57% of its earnings as a dividend. Labcorp Holdings, Inc. pays out 27.53% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios DGX or LH?
Quest Diagnostics, Inc. quarterly revenues are $2.8B, which are smaller than Labcorp Holdings, Inc. quarterly revenues of $3.5B. Quest Diagnostics, Inc.'s net income of $256M is higher than Labcorp Holdings, Inc.'s net income of $164.9M. Notably, Quest Diagnostics, Inc.'s price-to-earnings ratio is 23.12x while Labcorp Holdings, Inc.'s PE ratio is 27.03x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quest Diagnostics, Inc. is 2.07x versus 1.70x for Labcorp Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DGXQuest Diagnostics, Inc.2.07x 23.12x $2.8B $256M LHLabcorp Holdings, Inc.1.70x 27.03x $3.5B $164.9M
-
Which has Higher Returns DGX or WAT?
Waters Corp. has a net margin of 9.12% compared to Quest Diagnostics, Inc.'s net margin of 24.16%. Quest Diagnostics, Inc.'s return on equity of 14.49% beat Waters Corp.'s return on equity of 29.63%.
Company Gross Margin Earnings Per Share Invested Capital DGXQuest Diagnostics, Inc.32.57% $2.18 $13.7B WATWaters Corp.59.79% $3.77 $4B -
What do Analysts Say About DGX or WAT?
Quest Diagnostics, Inc. has a consensus price target of $217.38, signalling upside risk potential of 7.39%. On the other hand Waters Corp. has an analysts' consensus of $398.05 which suggests that it could grow by 20.46%. Given that Waters Corp. has higher upside potential than Quest Diagnostics, Inc., analysts believe Waters Corp. is more attractive than Quest Diagnostics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings DGXQuest Diagnostics, Inc.7 7 0 WATWaters Corp.10 12 0 -
Is DGX or WAT More Risky?
Quest Diagnostics, Inc. has a beta of 0.662, which suggesting that the stock is 33.785% less volatile than S&P 500. In comparison Waters Corp. has a beta of 1.180, suggesting its more volatile than the S&P 500 by 17.957%.
-
Which is a Better Dividend Stock DGX or WAT?
Quest Diagnostics, Inc. has a quarterly dividend of $0.80 per share corresponding to a yield of 1.58%. Waters Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quest Diagnostics, Inc. pays 36.57% of its earnings as a dividend. Waters Corp. pays out -- of its earnings as a dividend. Quest Diagnostics, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios DGX or WAT?
Quest Diagnostics, Inc. quarterly revenues are $2.8B, which are larger than Waters Corp. quarterly revenues of $932.4M. Quest Diagnostics, Inc.'s net income of $256M is higher than Waters Corp.'s net income of $225.2M. Notably, Quest Diagnostics, Inc.'s price-to-earnings ratio is 23.12x while Waters Corp.'s PE ratio is 30.96x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quest Diagnostics, Inc. is 2.07x versus 6.29x for Waters Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DGXQuest Diagnostics, Inc.2.07x 23.12x $2.8B $256M WATWaters Corp.6.29x 30.96x $932.4M $225.2M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 21
RingCentral, Inc. [RNG] is up 34.37% over the past day.
Sell
9
FROG alert for Feb 21
JFrog Ltd. [FROG] is down 24.98% over the past day.
Buy
72
SNSE alert for Feb 21
Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.
